The European Conference on Infections in Leukemia (ECIL) committee has recently updated its guidelines on antifungal prophylaxis for both pediatric and adult patients with hematologic malignancies, ...

BOSTON — The lack of data evaluating the clinical manifestations of adverse drug reactions before and during pregnancy shows need for more research in this area for this patient population ...

The WHO’s recommendation on screening pregnant women for intrapartum antibiotic prophylaxis offers a flexible framework for preventing early-onset GBS disease in newborns. While universal screening is ...

The guidelines for GBS prophylaxis were updated in 2020 by the American College of Obstetricians and Gynecologists. Universal GBS screening involves the screening of maternal colonization through ...

The prevalence of early neonatal sepsis was 1.9% (2/104) in patients with adequate prophylaxis and 0.0% (0/97) in patients with inadequate prophylaxis for GBS. Considering all cases included in the ...

Madhi SA, Izu A, Kwatra G, et al. Association of group B streptococcus (GBS) serum serotype-specific anticapsular immunoglobulin G concentration and risk reduction for invasive GBS disease in ...

1 Department of Pediatrics,Taixing People's Hospital, Taizhou, Jiangsu, China; 2 School of Clinical Medicine, Bengbu Medical College, Bengbu, Anhui, China; Objective: To investigate the associations ...

Clinical observation for 36-48 hours recommended for healthy newborns if mother had indication for GBS prophylaxis and received ≥ 4 hours of intrapartum antibiotics; ...

Results of a study published in Clinical Infectious Diseases found that an intrapartum antibiotic prophylaxis (IAP) program was associated with an expansion of Group B Streptococcus (GBS) clonal ...

A new report from the World Health Organization (WHO) and the London School of Hygiene & Tropical Medicine (LSHTM) reveals the alarming global impact of Group B streptococcus (GBS) – a common ...

Introduction. Guillain–Barré syndrome (GBS) is recognized as a paralytic peripheral neuropathy with an annual incidence of 0.81–1.89 cases (median, 1.11) per 100,000 persons worldwide (Benedetti et al ...